参考文献/References:
[1] APONTE-UBILLUS J J,BARAJAS D,PELTIER J,et al.Molecular design for recombinant adeno-associated virus(rAAV)vector production[J].Applied Microbiology and Biotechnology,2018,102:1045-1054.DOI:10.1007/s00253-017-8670-1.
[2] RABINOWITZ J,CHAN Yikai,SAMULSKI R J.Adeno-associated virus(AAV)versus immune response[J].Viruses,2019,11(2):102.DOI:10.3390/v11020102.
[3] BLANC F,MONDAIN M,BEMELMANS A P,et al.rAAV-mediated cochlear gene therapy: Prospects and challenges for clinical application[J].Journal of Clinical Medicine,2020,9:589.DOI:10.3390/jcm9020589.
[4] 刁勇,邱飞,肖卫东.重组腺相关病毒包装容量研究进展[J].中国生物工程杂志,2012,32(1):97-102.DOI:10.13523/j.cb.20120114.
[5] PRADO D A,ACOSTA-ACERO M,MALDONADO R S.Gene therapy beyond luxturna: A new horizon of the treatment for inherited retinal disease[J].Current Opinion in Ophthalmology,2020,31(3):147-154.DOI:10.1097/ICU.0000000000000660.
[6] DARROW J J.Luxturna: FDA documents reveal the value of a costly gene therapy[J].Drug Discovery Today,2019,24(4):949-954.DOI:10.1016/j.drudis.2019.01.019.
[7] MAGUIRE A M,RUSSELL S,WELLMAN J A,et al.Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: Results of phase 1 and 3 trials[J].Ophthalmology,2019,126(9):1273-1285.DOI:10.1016/j.ophtha.2019.06.017.
[8] 张国海,曾淑兰,许瑞安.在降低rAAV基因药物免疫反应中减少载体剂量并保持高效表达和药效的实施策略[J].药学学报,2013,48(3):305-314.DOI:10.16438/j.0513-4870.2013.03.010.
[9] 刁勇,许瑞安.重组腺相关病毒载体诱导的天然免疫反应及机制[J].微生物学报,2012,52(5):550-557.DOI:10.13343/j.cnki.wsxb.2012.05.002.
[10] MARKUSIC D M,HERZOG R W,ASLANIDI G V,et al.High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines[J].Molecular Therapy,2010,18(12):2048-2056.DOI:10.1038/mt.2010.172.
[11] WANG Jinhui,FAUST S M,RABINOWITZ J E.The next step in gene delivery: Molecular engineering of adeno-associated virus serotypes[J].Journal of Molecular and Cellular Cardiology,2011,50:793-802.DOI:10.1016/j.yjmcc.2010.10.017.
[12] MITCHELL A M,LI Chengwen,SAMULSKI R J.Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo[J].Journal of Virology,2013,87(8):4571-4583.DOI:10.1128/JVI.03443-12.
[13] SCHULTZ B R,CHAMBERLAIN J S.Recombinant adeno-associated virus transduction and integration[J].Molecular Therapy,2008,16(7):1189-1199.DOI:10.1038/mt.2008.103.
[14] ZHONG Li,ZHAO Weihong,WU Jianqing,et al.A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis[J].Molecular Therapy,2007,15(7):1323-1330.DOI:10.1038/sj.mt.6300170.
[15] DIAO Yong,MA Jian,XIAO Weidong,et al.Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin[J].World Journal of Gastroenterology,2007,13(34):4615-4619.DOI:10.3748/wjg.v13.i34.4615.
[16] XU Ruian,HARRISON P M,CHEN Miao,et al.Cytoglobin overexpression protects against damage-induced fibrosis[J].Molecular Therapy,2006,13(6):1093-1100.DOI:10.1016/j.ymthe.2005.11.027.
[17] XIAO Pengjie,LI Chengwen,NEUMANN A,et al.Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues[J].Molecular Therapy,2012,20(2):317-328.DOI:10.1038/mt.2011.250.
[18] JOHNSON J S,SAMULSKI R J.Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus[J].Journal of Virology,2009,83(6):2632-2644.DOI:10.1128/JVI.02309-08.
[19] 黄晓平,王晓,谢晓兰,等.Kallistatin通过Akt-eNOS 信号通路对肝星状细胞氧化损伤的保护作用[J].药学学报,2017,52(9):1397-1403.DOI:10.16438/j.0513-4870.2017-0199.
[20] SANLIOGLU S,BENSON P K,YANG Jusan,et al.Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation[J].Journal of Virology,2000,74(19):9184-9196.DOI:10.1128/jvi.74.19.9184-9196.2000.
[21] XIAO Pingjie,SAMULSKI R J.Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network[J].Journal of Virology,2012,86(19):10462-10473.DOI:10.1128/JVI.00935-12.
[22] SANLIOGLU S,ENGELHARDT J F.Cellular redox state alters recombinant adeno-associated virus transduction through tyrosine phosphatase pathways[J].Gene Therapy,1999,6(8):1427-1437.DOI:10.1038/sj.gt.3300967.